UK Investment Life Sci Firm Arix Bioscience Hits £100 Million IPO Goal
Arix Bioscience (LON:ARIX) rose to a modest premium in the first hour of trading in London.
The shares, listed at 207p, advanced 3p on thin volumes.
Arix raised £100mln as part of the float – money that will be ploughed into early-stage drug developers and university partnerships.
The shares, listed at 207p, advanced 3p on thin volumes.
Arix raised £100mln as part of the float – money that will be ploughed into early-stage drug developers and university partnerships.